For: | Onat A, Can G, Kaya A, Akbaş T, Özpamuk-Karadeniz F, Şimşek B, Çakır H, Yüksel H. Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality. World J Gastroenterol 2015; 21(48): 13555-13565 [PMID: 26730168 DOI: 10.3748/wjg.v21.i48.13555] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i48/13555.htm |
Number | Citing Articles |
1 |
Olubunmi Olujimisola Olubamwo, Jyrki K Virtanen, Jussi Pihlajamaki, Tomi-Pekka Tuomainen. Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study. BMJ Open 2019; 9(7): e026949 doi: 10.1136/bmjopen-2018-026949
|
2 |
Shengan Zhang, Zhidong Liu, Qinghua Yang, Zichun Hu, Wenjun Zhou, Guang Ji, Yanqi Dang. Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysis. BMJ Open 2023; 13(12): e074216 doi: 10.1136/bmjopen-2023-074216
|
3 |
Jing Zhou, Jing Fan, Xiaoyun Zhang, Lili You, Diaozhu Lin, Chulin Huang, Feng Li, Kan Sun. Fatty Liver Index and Its Association with 10-Year Atherosclerotic Cardiovascular Disease Risk: Insights from a Population-Based Cross-Sectional Study in China. Metabolites 2023; 13(7): 850 doi: 10.3390/metabo13070850
|
4 |
SamimAli Mondal, Deep Dutta, Manoj Kumar, Pankaj Singh, Madhurima Basu, Chitra Selvan, Satinath Mukhopadhyay. Neck circumference to height ratio is a reliable predictor of liver stiffness and nonalcoholic fatty liver disease in prediabetes. Indian Journal of Endocrinology and Metabolism 2018; 22(3): 347 doi: 10.4103/ijem.IJEM_31_18
|
5 |
Olubunmi O Olubamwo, Jyrki K Virtanen, Jussi Pihlajamäki, Tomi-Pekka Tuomainen. Association of fatty liver disease with mortality outcomes in an Eastern Finland male cohort. BMJ Open Gastroenterology 2019; 6(1): e000219 doi: 10.1136/bmjgast-2018-000219
|
6 |
L.K. Parkhomenko, L.A. Strashok, S.I. Turchyna, Z.V. Yeloyeva, T.M. Klymenko, H.V. Kosovtsova, D.A. Kashkalda, E.M. Zavelya, M.Y. Isakova, A.V. Yeshchenko, T.P. Kostenko. Mechanisms of hepatic steatosis formation in adolescent boys with hypoandrogenism. REPRODUCTIVE ENDOCRINOLOGY 2021; (57): 79 doi: 10.18370/2309-4117.2021.57.79-83
|
7 |
G. Craig Wood, Xin Chu, George Argyropoulos, Peter Benotti, David Rolston, Tooraj Mirshahi, Anthony Petrick, John Gabrielson, David J. Carey, Johanna K. DiStefano, Christopher D. Still, Glenn S. Gerhard. A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains. Scientific Reports 2017; 7(1) doi: 10.1038/srep43238
|
8 |
Pegah Golabi, James M. Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M. Younossi. Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. Hepatology Communications 2020; 4(8): 1136 doi: 10.1002/hep4.1534
|
9 |
Olubunmi O. Olubamwo, Jyrki K. Virtanen, Ari Voutilainen, Jussi Kauhanen, Jussi Pihlajamäki, Tomi-Pekka Tuomainen. Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction. European Journal of Gastroenterology & Hepatology 2018; 30(9): 1047 doi: 10.1097/MEG.0000000000001183
|
10 |
Fabrizia Carli, Silvia Sabatini, Melania Gaggini, Anna Maria Sironi, Giorgio Bedogni, Amalia Gastaldelli. Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk. International Journal of Molecular Sciences 2023; 24(19): 14651 doi: 10.3390/ijms241914651
|